- Home
- SEZL vs AMRX Comparison
SEZL vs AMRX Comparison
Compare SEZL & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEZL
- AMRX
- Stock Information
- Founded
- SEZL 2016
- AMRX 2002
- Country
- SEZL United States
- AMRX United States
- Employees
- SEZL N/A
- AMRX N/A
- Industry
- SEZL Diversified Financial Services
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SEZL Finance
- AMRX Health Care
- Exchange
- SEZL Nasdaq
- AMRX Nasdaq
- Market Cap
- SEZL 3.0B
- AMRX 3.3B
- IPO Year
- SEZL N/A
- AMRX N/A
- Fundamental
- Price
- SEZL $65.36
- AMRX $10.21
- Analyst Decision
- SEZL Buy
- AMRX Buy
- Analyst Count
- SEZL 4
- AMRX 3
- Target Price
- SEZL $113.75
- AMRX $12.00
- AVG Volume (30 Days)
- SEZL 709.8K
- AMRX 1.4M
- Earning Date
- SEZL 11-05-2025
- AMRX 10-30-2025
- Dividend Yield
- SEZL N/A
- AMRX N/A
- EPS Growth
- SEZL 146.46
- AMRX N/A
- EPS
- SEZL 2.93
- AMRX 0.01
- Revenue
- SEZL $371,794,890.00
- AMRX $2,852,914,000.00
- Revenue This Year
- SEZL $65.77
- AMRX $9.70
- Revenue Next Year
- SEZL $27.29
- AMRX $6.53
- P/E Ratio
- SEZL $23.97
- AMRX $970.62
- Revenue Growth
- SEZL 92.95
- AMRX 9.81
- 52 Week Low
- SEZL $24.86
- AMRX $6.69
- 52 Week High
- SEZL $186.74
- AMRX $10.68
- Technical
- Relative Strength Index (RSI)
- SEZL 28.00
- AMRX 52.54
- Support Level
- SEZL $70.63
- AMRX $10.13
- Resistance Level
- SEZL $80.00
- AMRX $10.62
- Average True Range (ATR)
- SEZL 4.46
- AMRX 0.28
- MACD
- SEZL -0.26
- AMRX -0.01
- Stochastic Oscillator
- SEZL 0.00
- AMRX 57.02
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.